Free Trial Information
BioCentury | Apr 9, 2007
Company News

Affinium Pharmaceuticals Inc. management update

...Ontario Business: Infectious, Computational chemistry/biology Hired: Barry Hafkin as CMO, formerly president and CEO of Cumbre...
Read More
BioCentury | Oct 2, 2006
Company News

Cumbre Pharmaceuticals Inc., TB Alliance deal

...TB and other neglected diseases, while Cumbre will have rights in other infectious disease areas. Cumbre...
Read More
BioCentury | Jun 19, 2006
Strategy

TB pipeline

...nitroimidazo- oxazole Otsuka Phase I Backup nitroimidazo-oxazole Otsuka Preclin DW-224 quinolone Dongwha Preclin Bifunctional molecules Cumbre...
Read More
BioCentury | Oct 31, 2005
Company News

Cumbre management update

Cumbre Inc. , Dallas, Texas Business: Infectious Hired: Barry Hafkin as CEO and president, formerly SVP and CSO at Advancis Pharmaceutical Corp. WIR Staff...
Read More
BioCentury | Oct 25, 2005
Company News

Cumbre names Hafkin CEO

...Barry Hafkin as CEO and president. Previously, Hafkin was SVP and CSO at Advancis (AVNC). Cumbre...
Read More
BioCentury | Oct 27, 2003
Company News

Cumbre other research news

...Science the identification of a series of bacterial RNAP inhibitors that inhibit nucleotide addition allosterically. Cumbre Inc....
Read More
BioCentury | Oct 15, 2001
Company News

Cumbre scientific advisory board update

Cumbre Inc., Dallas, Texas Business: Infectious diseases, Chemistry, High throughput screening Appointed: Richard Losick, professor of molecular and cellular biology at Harvard University, as chairman; Stephen Benkovic, professor of chemistry at Penn State University; Michael...
Read More
BioCentury | Sep 24, 2001
Finance

Ebb & Flow

...and Pictet Global Sector Fund. PTC has raised $56 million since its founding in 1998. Cumbre...
Read More
BioCentury | Sep 24, 2001
Company News

Cumbre management update

Cumbre Inc., Dallas, Texas Business: Infectious diseases, Chemistry, High throughput screening Hired: Bob England as president and CEO, formerly SVP and general manager for Texas Instruments Inc.'s digital imaging division WIR Staff...
Read More
BioCentury | Sep 20, 2001
Financial News

Cumbre raises $26 million

...therapeutics, raised $26 million in a private financing. Investors included Pharma Vision: and Vulcan Ventures. Cumbre...
...was spun out of Tularik (TLRK) in February, and originally was named Tularik Texas. Separately, Cumbre...
Read More
Items per page:
1 - 10 of 10
BioCentury | Apr 9, 2007
Company News

Affinium Pharmaceuticals Inc. management update

...Ontario Business: Infectious, Computational chemistry/biology Hired: Barry Hafkin as CMO, formerly president and CEO of Cumbre...
Read More
BioCentury | Oct 2, 2006
Company News

Cumbre Pharmaceuticals Inc., TB Alliance deal

...TB and other neglected diseases, while Cumbre will have rights in other infectious disease areas. Cumbre...
Read More
BioCentury | Jun 19, 2006
Strategy

TB pipeline

...nitroimidazo- oxazole Otsuka Phase I Backup nitroimidazo-oxazole Otsuka Preclin DW-224 quinolone Dongwha Preclin Bifunctional molecules Cumbre...
Read More
BioCentury | Oct 31, 2005
Company News

Cumbre management update

Cumbre Inc. , Dallas, Texas Business: Infectious Hired: Barry Hafkin as CEO and president, formerly SVP and CSO at Advancis Pharmaceutical Corp. WIR Staff...
Read More
BioCentury | Oct 25, 2005
Company News

Cumbre names Hafkin CEO

...Barry Hafkin as CEO and president. Previously, Hafkin was SVP and CSO at Advancis (AVNC). Cumbre...
Read More
BioCentury | Oct 27, 2003
Company News

Cumbre other research news

...Science the identification of a series of bacterial RNAP inhibitors that inhibit nucleotide addition allosterically. Cumbre Inc....
Read More
BioCentury | Oct 15, 2001
Company News

Cumbre scientific advisory board update

Cumbre Inc., Dallas, Texas Business: Infectious diseases, Chemistry, High throughput screening Appointed: Richard Losick, professor of molecular and cellular biology at Harvard University, as chairman; Stephen Benkovic, professor of chemistry at Penn State University; Michael...
Read More
BioCentury | Sep 24, 2001
Finance

Ebb & Flow

...and Pictet Global Sector Fund. PTC has raised $56 million since its founding in 1998. Cumbre...
Read More
BioCentury | Sep 24, 2001
Company News

Cumbre management update

Cumbre Inc., Dallas, Texas Business: Infectious diseases, Chemistry, High throughput screening Hired: Bob England as president and CEO, formerly SVP and general manager for Texas Instruments Inc.'s digital imaging division WIR Staff...
Read More
BioCentury | Sep 20, 2001
Financial News

Cumbre raises $26 million

...therapeutics, raised $26 million in a private financing. Investors included Pharma Vision: and Vulcan Ventures. Cumbre...
...was spun out of Tularik (TLRK) in February, and originally was named Tularik Texas. Separately, Cumbre...
Read More
Items per page:
1 - 10 of 10